MetAmyl: A METa-predictor for AMYLoid proteins

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Emily, Mathieu ^a,b,c   Talvas, Anthony ^b,d   Delamarche, Christian ^d  

^a AGROCAMPUS OUEST   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ RENNES 2   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; FIBRINOGEN;

ACCURACY; ALGORITHM; AMYLOIDOSIS; AREA UNDER THE CURVE; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; FRAMESHIFT MUTATION; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; METAMYL; MISSENSE MUTATION; POINT MUTATION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VALIDITY;

ALGORITHMS; AMINO ACIDS; AMYLOIDOGENIC PROTEINS; AMYLOIDOSIS; HUMANS; MODELS, MOLECULAR; PEPTIDES; POINT MUTATION;

EID: 84896736323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079722     Document Type: Article

References (71)

1. Jiménez JL, Guijarro J, Orlova E, Zuro J, Dobson CM, et al. (1999) Cryoelectron microscopy structure of an sh3 amyloid fibril and model of the molecular packing. The EMBO Journal 18: 815-821. (Pubitemid 29082261)
2. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nature Medicine 10: S10-S17. (Pubitemid 38901862)
3. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry 75: 333-366. (Pubitemid 44118036)
4. Dobson CM (2004) Experimental investigation of protein folding and misfolding. Methods 34: 4-14.
5. Nelson R, Eisenberg D (2006) Recent atomic models of amyloid fibril structure. Current Opinion in Structural Biology 16: 260-265.
6. Maury CPJ (2009) The emerging concept of functional amyloid. Journal of Internal Medicine 265: 329-334.
7. Lopez de la Paz M, Serrano L (2004) Sequence determinants of amyloid fibril formation. Proceedings of the National Academy of Sciences of the United States of America 101: 87-92.
8. Esteras-Chopo A, Serrano L, Lopez de la Paz M (2005) The amyloid stretch hypothesis: Recruiting proteins toward the dark side. Proceedings of the National Academy of Sciences of the United States of America 102: 16672-16677. (Pubitemid 41688835)
9. Wang X, Chapman MR (2008) Sequence determinants of bacterial amyloid formation. Journal of Molecular Biology 380: 570-580. (Pubitemid 351815136)
10. Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1698: 131-153. (Pubitemid 38591469)
11. Teng PK, Eisenberg D (2006) Short protein segments can drive a non-fibrilizing protein into the amyloid state. Protein Engineering, Design and Selection 16: 260-265.
12. Ventura S, Zurdo J, Narayanan S, Parreo M, Mangues R, et al. (2004) Short amino acid stretches can mediate amyloid formation in globular proteins: The src homology 3 (sh3) case. Proceedings of the National Academy of Sciences of the United States of America 101: 7258-7263. (Pubitemid 38638020)
13. Meng SR, Zhu YZ, Guo T, Liu XL, Chen J, et al. (2012) Fibril-forming motifs are essential and sufficient for the fibrillization of human tau. PLoS ONE 7: e38903.
14. Hamodrakas SJ (2011) Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies. FEBS Journal 278: 2428-2435.
15. Zibaee S, Makin OS, Goedert M, Serpell LC (2007) A simple algorithm locates - strands in the amyloid fibril core of -synuclein, a, and tau using the amino acid sequence alone. Protein Science 16: 906-918. (Pubitemid 46683195)
16. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, et al. (2006) The 3d profile method for identifying fibril-forming segments of proteins. Proceedings of the National Academy of Sciences of the United States of America 103: 4074-4078.
17. Goldschmidt L, Teng PK, Riek R, Eisenberg D (2010) Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proceedings of the National Academy of Sciences 107: 3487-3492.
18. Zhang Z, Chen H, Lai L (2007) Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23: 2218-2225. (Pubitemid 47423858)
19. Trovato A, Chiti F, Maritan A, Seno F (2006) Insight into the structure of amyloid fibrils from the analysis of globular proteins. PLoS Comput Biol 2: e170.
20. de Groot N, Pallares I, Aviles F, Vendrell J, Ventura S (2005) Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Structural Biology 5: 18.
21. Conchillo-Sole O, de Groot N, Aviles F, Vendrell J, Daura X, et al. (2007) Aggrescan: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65.
22. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, et al. (2008) Prediction of aggregation-prone regions in structured proteins. Journal of Molecular Biology 380: 425-436.
23. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nature Biotechnology 22: 1302-1306. (Pubitemid 39336784)
24. Frousios K, Iconomidou V, Karletidi CM, Hamodrakas S (2009) Amyloidogenic determinants are usually not buried. BMC Structural Biology 9: 44.
25. Tian J, Wu N, Guo J, Fan Y (2009) Prediction of amyloid fibril-forming segments based on a support vector machine. BMC Bioinformatics 10: 1-8.
26. Kim C, Choi J, Lee SJ,Welsh WJ, Yoon S (2009) Netcssp: web application for predicting chameleon sequences and amyloid fibril formation. Nucleic Acids Research 37: W469-W473.
27. Bryan AW Jr, Menke M, Cowen LJ, Lindquist SL, Berger B (2009) Betascan: Probable β-amyloids identified by pairwise probabilistic analysis. PLoS Comput Biol 5.
28. Garbuzynskiy SO, Lobanov MY, Galzitskaya OV (2010) Foldamyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics 26: 326-332.
29. Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nature Methods 7: 237-242.
30. De Baets G, Van Durme J, Reumers J, Maurer-Stroh S, Vanhee P, et al. (2012) Snpeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Research 40: D935-D939.
31. O'Donnell CW, Waldisphl J, Lis M, Halfmann R, Devadas S, et al. (2011) A method for probing the mutational landscape of amyloid structure. Bioinformatics 27: i34-i42.
32. Liaw C, Tung CW, Ho SY (2013) Prediction and analysis of antibody amyloidogenesis from sequences. PLoS ONE 8: e53235.
33. David MP, Concepcion G, Padlan E (2010) Using simple artificial intelligence methods for predicting amyloidogenesis in antibodies. BMC Bioinformatics 11: 79.
34. Rousseau F, Schymkowitz J, Serrano L (2006) Protein aggregation and amyloidosis: confusion of the kinds? Current Opinion in Structural Biology 16: 118-126. (Pubitemid 43221880)
35. Bellesia G, Shea JE (2009) Diversity of kinetic pathways in amyloid fibril formation. Journal of Chemical Physics 131: 111102.
36. Tsolis AC, Papandreou NC, Iconomidou VA, Hamodrakas SJ (2013) A consensus method for the prediction of aggregation-prone peptides in globular proteins. PLoS ONE 8: e54175.
37. R Core Team (2013) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org.
38. Venables WN, Ripley BD (2002) Modern Applied Statistics with S. Springer, fourth edition, 495 pp.
39. Hocking RR (1976) The analysis and selection of variables in linear regression. Biometrics 32: 1-49.
40. Miller AJ (1984) Selection of subsets of regression variables. J R Stat Soc (Ser A) 147: 389-425.
41. Miller AJ (2002) Subset selection in regression. Boca Raton, FL: Chapman and Hall/CRC, second edition.
42. Hastie T T, R, Friedman J (2009) The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer, second edition, 745 pp.
43. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) proc: an open-source package for r and s+ to analyze and compare roc curves. BMC Bioinformatics 12: 77.
44. Youden WJ (1988) Index for rating diagnostic tests. Cancer 3: 32-35.
45. Fändrich M, Meinhardt J, Grigorieff N (2009) Structural polymorphism of alzheimer aβ and other amyloid fibrils. Prion 3: 89-93.
46. Marshall KE, Serpell LC (2009) Insights into the structure of amyloid fibrils. The Open Biology Journal 2: 185-192.
47. Mossuto MF, Dhulesia A, Devlin G, Frare E, Kumita JR, et al. (2010) The noncore regions of human lysozyme amyloid fibrils influence cytotoxicity. Journal of Molecular Biology 402: 783-796.
48. Roland BP, Kodali R, Mishra R, Wetzel R (2013) A serendipitous survey of prediction algorithms for amyloidogenicity. Biopolymers.
49. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
50. Fawcett T (2006) An introduction to {ROC} analysis. Pattern Recognition Letters 27: 861-874.
51. Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R (1993) Telomere capture stabilizes chromosome breakage. Nature Genetics 3: 252-255.
52. Serpell LC, Benson M, Liepnieks JJ, Fraser PE (2007) Structural analyses of fibrinogen amyloid fibrils. Amyloid 14: 199-203. (Pubitemid 47262692)
53. Kang HG, Bybee A, Ha IS, Park MS, Gilbertson J, et al. (2005) Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen aβ-chain gene. Kidney International 68: 1994-1998. (Pubitemid 43117774)
54. Hamidi Asl L, Liepnieks JJ, Uemichi T, Rebibou JM, Justrabo E, et al. (1997) Renal amyloidosis with a frame shift mutation in fibrinogen aα-chain gene producing a novel amyloid protein. Blood 90: 4799-4805. (Pubitemid 28007193)
55. Mousson C, Heyd B, Justrabo E, Rebibou JM, Tanter Y, et al. (2006) Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen aα-chain gene. American Journal of Transplantation 6: 632-635. (Pubitemid 43382153)
56. Uemichi T, Liepnieks J, Yamada T, Gertz M, Bang N, et al. (1996) A frame shift mutation in the fibrinogen aα-chain gene in a kindred with renal amyloidosis. Blood 87: 4197-4203. (Pubitemid 26152264)
57. Gillmore JD, Lachmann HJ, Rowczenio D, Gilbertson JA, Zeng CH, et al. (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen aα-chain amyloidosis. Journal of the American Society of Nephrology 20: 444-451.
58. Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, et al. (2010) Hereditary fibrinogen aα-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 115: 2998-3007.
59. Neerman-Arbez M, Tirefort Y, de Moerloose P (2010) Can mutations identified in congenital fibrinogen disorders explain the clinical manifestations? Journal Of Coagulation Disorders 2: 1-9.
60. Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, et al. (2002) Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proceedings of the National Academy of Sciences 99: 16419-16426. (Pubitemid 35470988)
61. Uemichi T, Liepnieks JJ, Gertz MA, Benson MD (1998) Fibrinogen aα-chain leu 554: an African-american kindred with late onset renal amyloidosis. Amyloid 5: 188-192. (Pubitemid 128699446)
62. Flicek P, Amode MR, Barrell D, Beal K, Brent S, et al. (2012) Ensembl 2012. Nucleic Acids Research 40: D84-D90.
63. Hanss M, Biot F (2001) A database for human fibrinogen variants. Annals of the New York Academy of Sciences 936: 89-90. (Pubitemid 32613894)
64. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cbio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2: 401-404.
65. Pawar AP, DuBay KF, Zurdo J, Chiti F, Vendruscolo M, et al. (2005) Prediction of aggregation-prone and aggregation-susceptible regions in proteins associated with neurodegenerative diseases. Journal of Molecular Biology 350: 379-392. (Pubitemid 40805470)
66. Mosesson MW, Siebenlist KR, Hainfeld Jf, Wall JS, Soria J, et al. (1996) The relationship between the fibrinogen d domain self-association/cross-linking site (γxl) and the fibrinogen dusart abnormality (aα r554c-albumin): clues to thrombophilia in the "dusart syndrome". Journal of Clinical Investigation 97: 2342-2350-9.
67. Wolberg AS, Aleman MM (2010) Inuence of cellular and plasma procoagulant activity on the fibrin network. Thrombosis Research 125, Supplement 1: S35-S37.
68. Morris TA, Marsh JJ, Chiles PG, Magaa MM, Liang NC, et al. (2009) High prevalence of dys-fibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 114: 1929-1936.
69. Pawlicki S, Le Bechec A, Delamarche C (2008) Amypdb: A database dedicated to amyloid precursor proteins. BMC Bioinformatics 9: 273.
70. Belli M, Ramazzotti M, Chiti F (2011) Prediction of amyloid aggregation in vivo. EMBO Reports 12: 657-663.
71. Salvatella X (2013) Chapter four - structural aspects of amyloid formation. In: Giraldo J, Ciruela F, editors, Oligomerization in Health and Disease, Academic Press, volume 117 of Progress in Molecular Biology and Translational Science. pp. 73-101. doi:http://dx.doi.org/10.1016/B978-0-12- 386931-9.00004-0. URL http://www.sciencedirect.com/science/article/pii/ B9780123869319000040.